Vor Biopharma Inc.
VOR
$0.59
$0.04638.52%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.81% | 2.64% | -11.29% | -22.95% | -27.98% |
| Total Depreciation and Amortization | 1.03% | 9.99% | 87.34% | 22.55% | 38.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.17% | -20.22% | -33.70% | -16.70% | -5.83% |
| Change in Net Operating Assets | -99.23% | -334.64% | -768.36% | 61.15% | 106.61% |
| Cash from Operations | 0.63% | -5.30% | -21.75% | -23.10% | -17.79% |
| Capital Expenditure | 78.58% | 79.05% | 37.14% | 83.36% | 87.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.70% | 406.50% | 335.45% | 248.08% | 184.17% |
| Cash from Investing | 36.40% | 394.98% | 330.28% | 234.70% | 175.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,057.58% | -99.61% | -99.39% | -98.77% | -95.87% |
| Repurchase of Common Stock | 71.95% | 72.10% | 49.74% | -142.25% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -224.27% | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 1,717.29% | -99.89% | -99.78% | -99.57% | -97.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 292.02% | 149.19% | 242.69% | 105.27% | 57.57% |
